243 related articles for article (PubMed ID: 26138799)
1. Chronic hepatitis B: Are we close to a cure?
Loggi E; Vitale G; Conti F; Bernardi M; Andreone P
Dig Liver Dis; 2015 Oct; 47(10):836-41. PubMed ID: 26138799
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
Liaw YF
Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
[TBL] [Abstract][Full Text] [Related]
3. Novel viral and host targets to cure hepatitis B.
Ko C; Michler T; Protzer U
Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
[TBL] [Abstract][Full Text] [Related]
4. Immune responses in hepatitis B virus infection.
Rehermann B
Semin Liver Dis; 2003 Feb; 23(1):21-38. PubMed ID: 12616448
[TBL] [Abstract][Full Text] [Related]
5. Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?
Abu-Amara M; Feld JJ
Semin Liver Dis; 2013 May; 33(2):157-66. PubMed ID: 23749672
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic hepatitis B.
Loomba R; Liang TJ
Antivir Ther; 2007; 12 Suppl 3():H33-41. PubMed ID: 18284181
[TBL] [Abstract][Full Text] [Related]
7. Antiviral therapy for chronic hepatitis B.
Jafri SM; Lok AS
Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic viruses and hepatocellular carcinoma.
Ben Ari Z; Weitzman E; Safran M
Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
[TBL] [Abstract][Full Text] [Related]
9. A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
Han SH; Durazo FA; Saab S; Tong MJ
J Clin Gastroenterol; 2011 Mar; 45(3):259-66. PubMed ID: 20856136
[TBL] [Abstract][Full Text] [Related]
10. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
Brown A; Goodman Z
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
Asselah T; Marcellin P
Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies.
Seto WK
World J Gastroenterol; 2019 Jan; 25(3):282-286. PubMed ID: 30686897
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the treatment of HBV/HDV.
Krause A; Haberkorn U; Mier W
Eur J Pharmacol; 2018 Aug; 833():379-391. PubMed ID: 29935174
[TBL] [Abstract][Full Text] [Related]
17. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
18. Management of chronic hepatitis B infection.
Sundaram V; Kowdley K
BMJ; 2015 Oct; 351():h4263. PubMed ID: 26491030
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
Zhang Z; Zhang JY; Wang LF; Wang FS
J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection.
Liaw YF; Chu CM
Lancet; 2009 Feb; 373(9663):582-92. PubMed ID: 19217993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]